Eli Lilly and NVIDIA announced at the January 12, 2026 J.P. Morgan Healthcare Conference in San Francisco that they are creating a new AI co-innovation …
Read More
Owkin has entered its first collaboration with NVIDIA to advance the development of its biological large reasoning model, OwkinZero, using NVIDIA’s open AI infrastructure and …
Read More
Insilico Medicine reported first patient first dose in a Phase IIa clinical trial of its gut-restricted PHD inhibitor ISM5411, now assigned the generic name garutadustat. …
Read More
LinkedIn founder Reid Hoffman and Siddhartha Mukherjee’s Manas AI has entered a multi-year strategic agreement with Schrödinger, securing privileged access to its physics-based molecular modeling …
Read More
Boltz has launched as a public benefit corporation and paired the company formation with three operational announcements: a $28 million seed financing, a multi-year collaboration …
Read More
Aurora Therapeutics has launched with $16 million in seed funding from Menlo Ventures to pursue bespoke CRISPR-based therapies for ultra-rare genetic diseases. The company is …
Read More
